Cyclosporine-Associated Leukoencephalopathy in a Case of Sympathetic Ophthalmitis

摘要

PurposeCyclosporine (CsA) is currently widely used as a primary immunosuppressive agent in ocular disease, particularly in severe uveitis. Posterior reversible encephalopathy syndrome (PRES) is a significant complication of CsA therapy. However, there are no reports of the occurrence of PRES in response to the treatment of uveitis in the ophthalmological area.